↓ Skip to main content

Jinhua Qinggan granules for non-hospitalized COVID-19 patients: A double-blind, placebo-controlled, and randomized controlled trial

Overview of attention for article published in Frontiers in Medicine, August 2022
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (60th percentile)
  • Good Attention Score compared to outputs of the same age and source (71st percentile)

Mentioned by

twitter
6 X users

Readers on

mendeley
18 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Jinhua Qinggan granules for non-hospitalized COVID-19 patients: A double-blind, placebo-controlled, and randomized controlled trial
Published in
Frontiers in Medicine, August 2022
DOI 10.3389/fmed.2022.928468
Pubmed ID
Authors

Muhammad Raza Shah, Samreen Fatima, Sehrosh Naz Khan, Shafi Ullah, Gulshan Himani, Kelvin Wan, Timothy Lin, Johnson Y. N. Lau, Qingquan Liu, Dennis S. C. Lam

X Demographics

X Demographics

The data shown below were collected from the profiles of 6 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 18 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 18 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 4 22%
Student > Ph. D. Student 3 17%
Student > Bachelor 2 11%
Unknown 9 50%
Readers by discipline Count As %
Medicine and Dentistry 4 22%
Nursing and Health Professions 2 11%
Agricultural and Biological Sciences 1 6%
Engineering 1 6%
Unknown 10 56%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 11 March 2023.
All research outputs
#14,448,752
of 25,463,724 outputs
Outputs from Frontiers in Medicine
#2,418
of 7,213 outputs
Outputs of similar age
#169,952
of 432,342 outputs
Outputs of similar age from Frontiers in Medicine
#154
of 549 outputs
Altmetric has tracked 25,463,724 research outputs across all sources so far. This one is in the 42nd percentile – i.e., 42% of other outputs scored the same or lower than it.
So far Altmetric has tracked 7,213 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 13.6. This one has gotten more attention than average, scoring higher than 65% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 432,342 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 60% of its contemporaries.
We're also able to compare this research output to 549 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 71% of its contemporaries.